Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serine palmitoyltransferase long chain base subunit 1 pseudogene 1 (SPTLC1P1) is classified as a pseudogene and does not encode a functional protein. It is related by sequence to the protein-coding gene SPTLC1, which encodes a subunit of serine palmitoyltransferase, a critical enzyme in sphingolipid biosynthesis. SPTLC1P1 itself does not participate in enzymatic activity or known biological pathways; there is no evidence it serves as a drug target or biomarker, nor is it implicated in disease. Pseudogenes like SPTLC1P1 are generally regarded as nonfunctional DNA segments, though some pseudogenes in other contexts may have regulatory roles; none are described or confirmed for SPTLC1P1 in available data. SPTLC1 (not SPTLC1P1) is a protein-coding gene with a known biological role and disease associations such as hereditary sensory neuropathy type I. SPTLC1P1 is just one of several SPTLC1-related pseudogenes, with no evidence it is itself a therapeutic target or has related functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine palmitoyltransferase long chain base subunit 1 pseudogene 1 (SPTLC1P1).